Comment: Pharmacy and Generic Substitution of Antiepileptic Drugs: Missing in Action?

Abstract

Get full access to this article

View all access options for this article.

References

Welty

. Pharmacy and generic substitution of antiepileptic drugs: missing in action (editorial)? Ann Pharmacother 2007;41:1065–8. Epub 15 May 2007. DOI 10.1345/aph.1K076

Williams

. Therapeutic equivalence of generic drugs: response to the National Association of Boards of Pharmacy (letter). April 16, 1997. www.fda.gov/cder/news/ntiletter.htm (accessed 2007 May 28).

DeCara

Croze

Falk

. Generic warfarin: a cost effective alternative to brand-name drug or clinical wild card (editorial)? Chest 1998;113:261–3.

Hope

Havrda

. Subtherapeutic INR values associated with a switch to generic warfarin. Ann Pharmacother 2001;35:183–7. DOI 10.1345/aph.10207

Weibert

Yeager

Wittkowsky

. A randomized, crossover comparison of warfarin products in the treatment of chronic atrial fibrillation. Ann Pharmacother 2000;34:981–8. DOI 10.1345/aph.10068

Patterson

Mumdani

Naglie

Laupacis

. Clinical consequences of generic warfarin: an ecological study (letter). JAMA 2006;296:1969–72.